XLUMENA INC. / BOSTON SCIENTIFIC CORPORATION / WESTERN TECHNOLOGY INVESTMENT / THIRD POINT VENTURES L.P. / PRISM VENTURE PARTNERS / CHARTER LIFE SCIENCES / ASCENT BIOMEDICAL VENTURES / APERTURE VENTURE PARTNERS LLC / Private / Acquisition / £42m

Synopsis

Acquisition by Boston Scientific of Xlumena, a developer of products that enable advanced image-guided endoscopic therapy.

Principals

Xlumena Inc.

Boston Scientific Corporation

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

latham & watkins

HQ - New York, United States

legal advisors

bidder

5445

Deals

£ 3,505.44 B

Total Value